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Immunoreactive gastric inhibitory polypeptrde (IR-GIP) from human and porcine intestine was quantified 
by radioimmunoassay and the molecular forms characterised bygel permeation and reverse-phase high 
pressure liquid chromatography (HPLC). Gel filtration revealed two major immunoreactive peaks 
corresponding to the previously described S-kDa and 8-kDa molecular forms, which appeared similar m 
both species. Isocratic reverse-phase HPLC revealed that the major inununoreactive GIP peak (5-kDa) in 
the human tissue luted earlier than the corresponding porcine molecular form, indicating the latter to be 
less hydrophobic. These findings uggest ignificant species differences between human and porcine GIP. 
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1. INTRODUCTION 
GIP is a 42 amino acid polypeptide hormone 
which has been known as both gastric acid in- 
hibitory polypeptide [l] and glucose-dependent in- 
sulinotropic polypeptide [2,3]. The polypeptide 
was initially isolated from porcine upper small in- 
testine [4] where it has been localised to a discrete 
endocrine cell type called the K cell [S]. This and 
other studies [6,7] have demonstrated the existence 
of two immunoreactive peaks of GIP eluting from 
gel columns. The major immunoreactive peak 
elutes later and in the position of the pure porcine 
GIP standard (5 kDa); the early peak of a larger 
molecular form, as yet not isolated, has an 
estimated molecular mass of 8 kDa. Reverse-phase 
high pressure liquid chromatography (HPLC) of 
partially purified porcine GIP [8] has revealed 3 
peaks denoted as I, II and III. Peak III is the major 
peak and is the 5-kDa molecular form. One of the 
other peaks has been speculated to be des- 
Tyrr-Ala*-GIP [8]. 
IR-GIP is regularly measured by radioim- 
munoassay using porcine GIP as standard 
[6,9-111. Although it is assumed that human GIP 
is very similar to porcine GIP, the human form is 
as yet uncharacterised. Concentrations of IR-GIP 
in human subjects vary widely depending on which 
laboratory performs the radioimmunoassay [6,12]. 
This study was undertaken to determine whether 
porcine and human IR-GIP are identical using gel 
permeation and reverse-phase HPLC techniques. 
2. EXPERIMENTAL 
Fresh porcine duodenum was removed from 4 
healthy pigs (mean weight 36 f 4 kg) immediately 
after death. The mucosal layer was dissected from 
the underlying muscle and extracted. The tissue 
was diced and then plunged into boiling 0.5 M 
acetic acid for 10 min [3]. The extracts were stored 
at -20°C and briefly thawed and centrifuged 
prior to radioimmunoassay and chromatography. 
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Human duodenum was obtained at post mortem 
and IR-GIP extracted in an identical manner to the 
porcine tissue and stored at -20°C. 
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Tissue concentrations of IR-GIP were deter- 
mined using the radioimmunoassay in [6]. Briefly, 
the antibody appears to require the entire sequence 
for complete cross-reaction as neither large C- nor 
N-terminal fragments react. The antibody does not 
cross-react with any other known peptide hormone 
other than natural pancreatic glucagon (1% cross- 
reaction) and can detect changes of 0.8 fmol/tube 
with 95% confidence. Gel permeation was per- 
formed on a 100 x 1.5 cm column of Sephadex 
G-50 superfine (Pharmacia) eluted with 0.06 M 
phosphate buffer (pH 7.4) containing 0.15 mmol/l 
bovine serum albumin and 0.2 M sodium chloride 
at a flow rate of 12.3 ml/h. Fractions of 2.2 ml 
were collected and assayed for IR-GIP. All gel 
chromatography was carried out at 4OC. Elution 
constants (Kav) were calculated as in [ 141. Isocratic 
reverse-phase HPLC was performed on the gel- 
filtered peaks of 5-kDa IR-GIP on an 
octadecylsilicyl-silica column (5 pm Techsil ClS, 
HPLC Technology Ltd, Cheshire) using 32.5% 
acetonitrile/water with 0.2% trifluoroacetic acid 
as eluent. The flow rate was 1 ml/min and l-ml 
fractions were collected and assayed for IR-GIP. 
Prior to HPLC gel-filtered extracts and standards 
were prepared on activated micro-Bondapak Cis 
cartridges (Sep-pak, Waters) eluted with 50% 
acetonitrile/water with 0.2% trifluoroacetic acid. 
After centrifugation (12000 x g for 5 min) this was 
further diluted to 25% acetonitrile before injec- 
tion. Oxidation of the pure porcine standard 
(10 pmol) was performed by adding 10 pl of 0.3 M 
hydrogen peroxide and allowing to react for 
45 min. The reaction was terminated by the addi- 
tion of 700 ~1 of 2 M acetic acid. After preparation 
the sample was columned on the HPLC system. 
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Fig.1. Sephadex G-50 gel filtration of GIP- 
rmmunoreactive material from porcine and human 
duodenal mucosa. Samples for chromatography were 
centrifuged and the supernatant applied to a 1 m x 
100 cm column (Pharmacra) of G-50 superfine 
(Pharmacra) and equilibrated with 0.06 M phosphate 
buffer (pH 7.4) contannng 0.15 M BSA (Miles). The 
column was eluted with the same buffer. Fractions 
(2.2 ml) were collected at a flow rate of 12.3 ml/h and 
assayed by radioimmunoassay for IR-GIP. The column 
was previously calibrated with Dextran blue and “s1. 
The profile obtained with the pure porcine GIP 
(courtesy of J.C. Brown; M 5100) is included. 
3. RESULTS 
respectively). The early peak comprised 13% of 
total IR-GIP. Pure porcine standard eluted with a 
Kav of 0.54 f O.Ol.(n = 4). 
IR-GIP concentrations in human and porcine On isocratic reverse-phase HPLC, gel-filtered 
duodenal mucosa were 108.4 f 16.1 and 80.8 f porcine duodenal mucosa IR-GIP (of Kav 0.53) was 
21.2 pmol/g, respectively. The gel filtration pro- resolved into 3 components (fig.2): two small 
files obtained are shown in fig. 1. Porcine IR-GIP peaks eluting at 11 and 15 min and the major peak 
eluted in two major peaks - an early peak with a eluting last (21 min) and coinciding with the elu- 
Kav of 0.31 f 0.01 (n = 4) and a subsequent much tion of the pure porcine standard under identical 
larger peak with a Kav of 0.53 f 0.02 (n = 4). The conditions. The profile of the elution of the human 
early peak comprised 8% of total IR-GIP. The duodenal IR-GIP from a gel column (K,, 0.55) also 
profile of human duodenal IR-GIP was very revealed 3 peaks - as with the porcine tissue 2 
similar to the porcine one and the K,, values were small peaks at 9 min and 13 min retention time 
almost identical (0.33 f 0.01 and 0.55 + 0.02, preceded the elution of the major immunoreactive 
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Fig.2. Isocratic reverse-phase HPLC of IR-GIP of the 
major peak (Kav 0.54) obtained by Sephadex G-50 gel 
filtration of human and porcine duodenal mucosa. 
Samples were prepared (see text) and applied to a 5 pm 
Techsil Cis column (HPLC Technology Ltd) 
equilibrated in 32.5% acetonitrile/water with 0.2% 
trifluoroacetic acid. The column was eluted with this 
buffer at a flow rate of 1 ml/min and l-ml fractions 
collected. These were assayed for IR-GIP. The column 
was washed with 50% acetomtrile, 0.2% trlfluoroacetic 
acid with water at the end of each run and then re- 
equilibrated with the eluting buffer. 
peak (17 mm). The major peak in the human tissue 
eluted before the corresponding porcine IR-GIP 
peak. 
Oxidation of the pure porcine standard yielded 
3 peaks: a major peak coinciding with the elution 
of the natural, unoxidised porcine standard and 
two small peaks coinciding with the elution of 
peaks at 11 and 15 min on the porcine duodenal 
extract HPLC profile. Further HPLC runs with 
50% acetonitrile/0.2% trifluoroacetic acid failed 
to elute any other major immunoreactive peaks 
(< 1% of total IR-GIP) of either human or porcine 
GIP. Recoveries from both G-50 and HPLC col- 
umns were between 82 and 104%. 
4. DISCUSSION 
The elution constants &) of the major 
molecular forms of IR-GIP obtained from gel 
filtration studies agree with data in [4,6]. These 
molecular forms have been estimated to be 8 kDa 
(Kav = 0.32) and 5 kDa (Kav = 0.55). There is no 
apparent difference between porcine and human 
IR-GIP molecular forms from gel chromato- 
graphy. However the HPLC profiles clearly dif- 
ferentiate between the major molecular form 
(5 kDa) of human and porcine duodenal IR-GIP. 
The human form elutes before the porcine IR-GIP 
of similar size indicating it is less hydrophobic. 
There are two other peaks of IR-GIP in both gel- 
filtered human and pig extracts which are of 
similar molecular size. These peaks were also 
generated by oxidation of the porcine standard. 
One is likely to represent the sulphoxide of the 
single methionine residue of porcine GIP; the 
other has been suggested to be des-Tyrr-Ala’-GIP 
PI. 
Reverse-phase HPLC studies of partially 
purified GIP of porcine origin have revealed 3 
peaks of IR-GIP [8]. The latter study employed 
much greater concentrations of peptide and a dif- 
ferent solvent system and though recovery was 
< 10% the profile appears very similar to that 
obtained here. 
In conclusion, the findings show a species dif- 
ference between human and porcine IR-GIP, the 
former being a less hydrophobic moiety. This dif- 
ference in hydrophobicity is also evident in the ox- 
idation/fragmentation products of the 5-kDa IR- 
GIP. 
There is considerable controversy as to whether 
GIP plays an important role in the entero-insular 
axis [15]. Infusion of porcine GIP into man 
reproducing plasma concentrations seen after a 
meal fails to enhance significantly insulin release to 
IV glucose [16]. 
The difference between porcine and human IR- 
GIP however may lead to unequal cross-reaction 
of the two forms with various antibodies, which 
may partly explain the non-agreement in human 
IR-GIP concentrations as measured by different 
porcine GIP antibodies in various laboratories 
[6,12,17]. It is therefore possible that porcine GIP 
reagents underestimate the post-prandial rise of 
GIP in man (though it is remarkably similar in 
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magnitude to that seen in the pig). Thus infusion 
experiments to test the entero-insular axis in man 
may have employed insufficient GIP. Further- 
more, the different molecular forms could possess 
different biological activities, so that porcine GIP 
infusions in man may be less active than the en- 
dogenous peptide. While endogenous GIP release 
by fat in man also failed to enhance significantly 
insulin release to IV glucose full exploration of the 
entero-insular axis in man must now await 
purification of human GIP. 
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